MIRRA ANDREEVA WINS FRENCH OPEN AT 19, BECOMES YOUNGEST WOMEN’S CHAMPION SINCE MONICA SELES . (PHOTO).

-
Image
 Mirra Andreeva wins French Open at 19, becomes youngest women’s champion since Monica Seles   Russian tennis star Mirra Andreeva completed a breakout run at the French Open on Saturday, defeating Polish qualifier Maja Chwalinska 6-3, 6-2 to capture her first Grand Slam title at age 19. Andreeva, who was already regarded as a prodigy after emerging on the WTA Tour as a teenager, became the youngest women’s singles champion since Monica Seles, who was 18 when she won her third straight French Open in 1992. Ranked eighth in the world, she controlled the final in Paris, taking command after dropping just a few early games. The match shifted decisively when Andreeva won nine consecutive games to seize control, eventually closing out the victory with a backhand winner on match point before falling to her knees in celebration on the clay. She finished with 25 winners compared to Chwalinska’s 10 and committed fewer unforced errors in a match played under windy conditions at Cour...
Post a Comment

RUSSIA ANNOUNCED FIRST mRNA-BASED CANCER VACCINE. (PHOTO).

-


 Russia has made a major medical breakthrough with the announcement of its first mRNA-based cancer vaccine, which will be available for free to patients starting early 2025. The development was confirmed by Andrey Kaprin, General Director of the Radiology Medical Research Center under the Russian Ministry of Health, during an interview with Radio Rossiya. Pre-clinical trials have shown that the vaccine effectively suppresses tumor growth and potential metastases, according to Alexander Gintsburg, Director of the Gamaleya National Research Center for Epidemiology and Microbiology. However, the name of the vaccine is yet to be disclosed.


The Russian government views this vaccine as a significant step in addressing the country’s rising cancer rates. In 2022 alone, over 635,000 new cancer cases were reported in Russia, with colon, breast, and lung cancers being the most prevalent. Earlier this year, President Vladimir Putin highlighted in a televised address that the country was nearing the creation of next-generation cancer vaccines and immunomodulatory drugs, promising hope for millions of patients.


Cancer vaccines, such as the one developed by Russia, work by stimulating the immune system to target cancer cells more effectively. These vaccines are designed to identify and attack tumor-specific proteins, slowing tumor growth or preventing recurrence. Similar advancements are being made globally, with vaccines like the HPV shot already proving effective in preventing cancers linked to viral infections, such as cervical cancer.


Russia’s achievement joins efforts by other nations in the race to develop personalized cancer vaccines. Earlier this year, researchers at the University of Florida tested a vaccine for glioblastoma, an aggressive brain cancer, and reported strong immune responses in patients. Meanwhile, in the UK, a personalized vaccine for melanoma has shown promising results, improving survival rates in patients. These advancements underline the global focus on innovative cancer treatments, which could redefine oncology in the near future.

Comments

Post a Comment

Popular posts from this blog

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

-
Image
             Gerard Pique,welcomed their first child into the world last year January.Shakira told the magazine that ''I think it takes two to keep it passionate in relationships,a lot of laughter and a lot of fun moments together,that's essential but also affinity,you know.You have to be compatible.I'm really happy where i am right now,with the person that i'm with right now.He seems to want the same things i want,and that's very important''.More pictures below.                                                                                                                    
Read more

THE NEW OONI OF ILE-IFE,WILL NOT EAT THE HEART OF THE LATE OONI-PALACE CHIEFS.

-
Image
                           According to the Araba of Osogboland Chief Yemi Elebuibon,debunk the rumors that the new Ooni will eat the heart of the late Ooni of Ife as custom demands,so he cleared the air when he recently said that ''The heart of the late king would not be fed to the next Ooni.The eating of the heart of a departed King by an incoming one belonged to the past.It no longer exists.People still make this insinuation because many are barred from witnessing the burial of a king.What the incoming king will eat is the heart of an animal and not that of a human.Nobody will be buried with the Ooni.Nobody would be killed for any form o sacrifice''.Thank God he clarified the part that no one will be buried with the Ooni,because the rumors going round is that the Sarun,otherwise known as Abobakun,is on the run,to escape being buried with the late Ooni of Ife.Lowa Adimula of Ife,Oba Joseph Ijaodola,who is the Head o...
Read more

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

-
Image
Innoson Gives Out Brand New IVM G5 and Salary For Life To The Man Who Prophesied About His Vehicle Manufacturing In 1979.  Last Saturday, July 22nd the Chairman of Innoson Vehicle Manufacturing Company Ltd, Chief Dr Innocent Ifediaso Chukwuma OFR gave out a brand new Innoson IVM G5 to Mr Ikechukwu Osakwe popularly known as Osabros who prophesied to him in 1979 that he would be the first man in Africa to manufacture vehicles and sell to different African countries.  The prophecy was given at the period the then Innocent Chukwuma could not boast of a car, talk less of manufacturing one. According to Dr Chukwuma during the presentation of the car, he recalled on how Mr Ikechukwu Osakwe all the way from Kano blocked him at the front of his house early in the morning and told him he has a message for him.  Mr Osakwe went on to narrate a dream he had about him, how he saw in the said dream his vehicle manufacturing company known as CAP PLC. "He told me that CAP means Chukwuma ...
Read more